As of 2024-12-14, the Fair Value of Celadon Pharmaceuticals PLC (CEL.L) is -41.80 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 19.00 GBP, the upside of Celadon Pharmaceuticals PLC is -319.99%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-08-31 | 2021-08-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -0.17 | -0.47 | -4.63 | -17.01 | -7.14 | -5.88 |
| YoY growth | 8.79% | -171.05% | -878.41% | -267.46% | 58.01% | -250.02% |
| Market Cap (mil) | 11.89 |
| P/E | |
| Forward P/E |
| EPS | -8.36 |
| Avg earnings growth rate | -250.02% |
| TTM earnings | -5.23 |